4.   Add an additional 20      l of 0.1    M imidazole, pH 6.0. Mix and react for at least 2 hours 
at room temperature. The additional buffer prevents pH drift during the carbodiimide 
reaction.  
  5.   Purify the hydrazide-labeled oligo by gel fi ltration on a desalting resin using 10    mM
sodium phosphate, 0.15    M NaCl, 10    mM EDTA, pH 7.2. The hydrazide-containing probe 
now may be used to conjugate with a molecule containing an aldehyde-reactive group.       
  4.6.        Introduction  of  Saccharide  or  Glycan  Groups 
The modifi cation of proteins with sugar groups occurs  in vivo through both enzymatic and non-
enzymatic processes. Approximately 1 percent of proteins encoded in the genomes of mammals 
are enzymes that are involved with carbohydrate production or modifi cation. Many of these 
enzymes digest carbohydrate in foods to provide energy for cellular metabolism, but others 
are involved with the controlled modifi cation of proteins or other biomolecules to create com-
plex polysaccharide structures. This process results in carbohydrates, called glycans, covalently 
attached to proteins at discrete locations on only certain amino acid residues within a polypep-
tide sequence (Section 2, this chapter). The presence of carbohydrate modifi cations on proteins 
has a pronounced effect on biological activity in vivo . 
Non-enzymatic modifi cation of proteins with saccharides also occurs in vivo through uncon-
trolled glycation of lysine amines with the reducing end of sugars, especially glucose. This reac-
tion results in the formation of an initial Schiff base with a subsequent rearrangement to form 
a stable ketoamine derivative. The non-enzymatic glycation reaction has been studied exten-
sively as a result of it being a major factor in the development of the complications associated 
with diabetes (for review, see Singh  et al ., 2001). 
  In vitro modifi cation of protein can be done synthetically to add specifi c sugars or com-
plex carbohydrates to proteins for further bioconjugation or for subsequent study of the 
glycan-derivative in vivo. Investigations of the effect of these synthetic carbohydrate–protein 
conjugates (neoglycoproteins) on the immune response date back many decades with the dia-
zonium-mediated coupling of aminophenol glucosides to study type-II and type-III pneumonia 
polysaccharides (Goebel et al., 1932). More recently, conjugation of carbohydrates to pro-
tein carriers has been done to illicit a specifi c immune response to glyco-antigens of infectious 
diseases or tumor cells (Toyokuni and Singhal, 1995; Koganty  et al., 1996; Ragupathi et al ., 
1997; Pozsgay, 1998; Mawas  et al., 2002; Karsten et al., 2004). Synthetic peptide–glycan con-
jugates also have been prepared by conjugation of carbohydrates to peptide sequences that can 
be presented by MHC (major histocompatibility complex) molecules to enhance the immune 
response against the carbohydrate component (Kihlberg and Magnusson, 1996). For an excel-
lent review of glycoconjugation, see Davis (1999). 
Sugar residues also can be used to modify a protein, molecule, or surface for subsequent use 
in a bioconjugation procedure or to increase the hydrophilicity of the modifi ed molecule. For 
bioconjugation purposes, a sugar group can be added to facilitate the covalent conjugation of 
another molecule. Since many saccharides contain diols that can be oxidized by periodate to cre-
ate aldehydes, certain sugars can be used after glycol oxidation to couple with amine-contain-
ing molecules by reductive amination. For instance, the amine group on the monosaccharide 
glucosamine can be coupled to an amine-reactive surface or to a protein through its carboxy-
late groups using EDC (Chapter 3, Section 1.1). The glucosamine-modifi ed surface or molecule 
4.  Creating Specifi c Functionalities  147